Literature DB >> 15459079

Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.

Jan Kassubek1, Freimut D Juengling, Daniel Ecker, G Bernhard Landwehrmeyer.   

Abstract

The pattern of motor, behavioral and cognitive symptoms in Huntington's disease (HD) implicates dysfunction of basal-ganglia-thalamo-cortical circuits. This study explored if cognitive performance in HD is correlated with localized cerebral changes. Psychomotor functions were investigated by verbal fluency, Stroop color word and Digit Symbol tests in 44 HD patients and 22 controls. Three-dimensional magnetic resonance imaging (MRI) data were analyzed with regard to regional gray matter changes by use of the observer-independent whole-brain-based approach of voxel-based morphometry (VBM). Using statistical parametric mapping, the MRI data of the HD patients were analyzed in an ANCOVA including the individual results of the neuropsychological tests. Besides striatal areas, symmetrical regional atrophy of the thalamus was found to co-vary significantly with cognitive performance (P < 0.001, corrected for multiple comparisons). In particular, thalamic subnuclei projecting to prefrontal areas (dorsomedial subnucleus) and connected to the striatum (centromedian/parafascicular and ventrolateral nuclear complex) displayed volume loss, in agreement with neuropathological studies. These results suggest that thalamic degeneration contributes in an important way to the impairment of executive function in early HD. Patients who are impaired in executive tests display structural double lesions of the basal-ganglia-thalamo-cortical circuitry both at the striatal and at the thalamic level.

Entities:  

Mesh:

Year:  2004        PMID: 15459079     DOI: 10.1093/cercor/bhh185

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  63 in total

1.  Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Authors:  J Jean Chen; David H Salat; H Diana Rosas
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

Review 2.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure.

Authors:  Brian S Schwartz; Sining Chen; Brian Caffo; Walter F Stewart; Karen I Bolla; David Yousem; Christos Davatzikos
Journal:  Neuroimage       Date:  2007-06-02       Impact factor: 6.556

4.  Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry.

Authors:  Christian Beste; Carsten Saft; Carsten Konrad; Jürgen Andrich; Anne Habbel; Inga Schepers; Andreas Jansen; Bettina Pfleiderer; Michael Falkenstein
Journal:  Hum Brain Mapp       Date:  2008-02       Impact factor: 5.038

5.  Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.

Authors:  Susie M D Henley; Edward J Wild; Nicola Z Hobbs; Rachael I Scahill; Gerard R Ridgway; David G Macmanus; Roger A Barker; Nick C Fox; Sarah J Tabrizi
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

6.  Increasing CREB in the auditory thalamus enhances memory and generalization of auditory conditioned fear.

Authors:  Jin-Hee Han; Adelaide P Yiu; Christina J Cole; Hwa-Lin Hsiang; Rachael L Neve; Sheena A Josselyn
Journal:  Learn Mem       Date:  2008-05-30       Impact factor: 2.460

Review 7.  The elusive nature of executive functions: a review of our current understanding.

Authors:  María Beatriz Jurado; Mónica Rosselli
Journal:  Neuropsychol Rev       Date:  2007-09-05       Impact factor: 7.444

8.  MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths.

Authors:  Jorge Jovicich; Silvester Czanner; Xiao Han; David Salat; Andre van der Kouwe; Brian Quinn; Jenni Pacheco; Marilyn Albert; Ronald Killiany; Deborah Blacker; Paul Maguire; Diana Rosas; Nikos Makris; Randy Gollub; Anders Dale; Bradford C Dickerson; Bruce Fischl
Journal:  Neuroimage       Date:  2009-02-20       Impact factor: 6.556

9.  Monitoring Huntington's disease progression through preclinical and early stages.

Authors:  Chris Tang; Andrew Feigin
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.